Getting a hair loss diagnosis and a prescription in the same appointment can feel like a lot to process at once — especially when the diagnosis itself involves some uncertainty. It’s a genuinely common position to be in: a dermatologist offers a reasonable-sounding treatment plan, but the person leaving the office is left with more questions than they walked in with.
Why hair loss diagnoses aren’t always clear-cut immediately
Hair loss can have more than one contributing cause, and it isn’t unusual for a dermatologist to suspect an overlap — for example, a temporary shedding event like telogen effluvium happening alongside the start of androgenetic (pattern) hair loss. According to the American Academy of Dermatology, telogen effluvium is often triggered by physical stress on the body — illness, significant weight loss, surgery, or high fever — and typically resolves on its own within about six months to a year, though regrowth timelines vary. Androgenetic alopecia, by contrast, is a separate, typically progressive pattern that generally benefits from ongoing treatment rather than resolving on its own.
A visual exam without additional tools like trichoscopy can make it harder to fully distinguish between the two in a single visit, which is part of why some dermatologists proceed with a treatment plan and a fairly short follow-up window (rather than waiting for total certainty) — regrowth response over the following weeks can itself be diagnostically useful.
What minoxidil and finasteride generally do
Topical minoxidil is FDA-approved for pattern hair loss and works by prolonging the hair growth cycle; it does not require a specific underlying diagnosis to be considered reasonably safe to try, according to AAD treatment guidance. Finasteride works differently, by reducing DHT, a hormone linked specifically to androgenetic hair loss — it targets pattern hair loss mechanisms and is not expected to have a specific effect on telogen effluvium, though it’s commonly prescribed together with minoxidil when a clinician suspects pattern hair loss may be present or developing.
Initial shedding in the first several weeks of starting minoxidil is a well-documented, usually temporary phase as the hair growth cycle resets — it is not necessarily a sign that treatment is failing, per general AAD patient guidance, though it can understandably be alarming to experience.
Questions worth bringing to a follow-up appointment
Rather than trying to resolve uncertainty alone, these are reasonable, specific questions to raise at a follow-up visit:
- Would trichoscopy or a pull test at follow-up help clarify whether this is primarily telogen effluvium, androgenetic alopecia, or both?
- Is there a reason the higher (10%) minoxidil concentration was chosen over the more commonly used 5%, and are there different side-effect considerations at that strength?
- If shedding is mostly telogen effluvium related to prior illness, is there a recommended reassessment point for stepping down or stopping minoxidil rather than continuing indefinitely?
- What does the realistic long-term picture look like — is this framed as an open-ended maintenance treatment, or will that be reassessed based on how hair responds?
On the fear of “committing” to treatment
It’s a common and understandable concern — minoxidil in particular is generally understood to require continued use to maintain results, and stopping can lead to a return of shedding within months, per AAD guidance. That’s a legitimate factor to weigh, including practical ones like ongoing cost. It’s a reasonable topic to be upfront about with a prescribing dermatologist, including asking about lower-cost formulations or generic options, rather than making a long-term decision under uncertainty alone.
None of this is a substitute for the dermatologist’s in-person assessment, but going into a follow-up with specific, informed questions can make that three-week wait more productive.
This article is for general educational purposes only and does not constitute medical advice. Do not start, stop, or change any medication or dosage without consulting your prescribing physician or dermatologist.
— Gemifys
